Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the addition of ZEN003694 to the standard chemotherapy capecitabine for metastatic or unresectable colorectal cancers, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• ZEN003694

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: RECRUITING